慢性乙肝-话题@MedSci

#慢性乙肝#

38篇内容 | 1412人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2157430, encodeId=b051215e43033, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a> 坚持学习打卡谢谢分享谢谢, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=23, createdTime=2023-09-12, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=https://img.medsci.cn/20220201/358c07958b744197a7c86437de41eaae/122444a699eb4ccab6505301ec608ab8.jpg, status=1, hasArticle=0, attachment=null, ipAttribution=山东省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2147774, encodeId=46ca214e774ea, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a> 少熬夜，多运动，预防乙肝, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=37, createdTime=2023-07-13, rootId=0, userName=13d0179fm99暂无昵称, userId=65724176436, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=山西省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143362, encodeId=79552143362a9, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>慢性乙肝防治，任重道远, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=19, createdTime=2023-06-17, rootId=0, userName=13d0179fm99暂无昵称, userId=65724176436, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2139950, encodeId=80162139950ac, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>少熬夜，多运动，预防慢性乙肝, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=26, createdTime=2023-05-30, rootId=0, userName=13d0179fm99暂无昵称, userId=65724176436, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2139051, encodeId=30772139051a7, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>坚持学习谢谢分享谢谢, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=24, createdTime=2023-05-25, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=https://img.medsci.cn/20220201/358c07958b744197a7c86437de41eaae/122444a699eb4ccab6505301ec608ab8.jpg, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2126450, encodeId=802c21264500a, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>增强体质，预防乙肝, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=29, createdTime=2023-04-17, rootId=0, userName=13d0179fm99暂无昵称, userId=65724176436, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2094230, encodeId=3b2020942301b, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>坚持学习谢谢分享谢谢分享谢谢, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=37, createdTime=2022-10-17, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=https://img.medsci.cn/20220201/358c07958b744197a7c86437de41eaae/122444a699eb4ccab6505301ec608ab8.jpg, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1249479, encodeId=a4a912494e9dd, content=<a href='/topic/show?id=68ca828e57' target=_blank style='color:#2F92EE;'>#GSK#</a>宣布，<a href='/topic/show?id=7826104e2900' target=_blank style='color:#2F92EE;'>#bepirovirsen#</a>（<a href='/topic/show?id=a368103860f9' target=_blank style='color:#2F92EE;'>#GSK3228836#</a>、GSK836）治疗<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>的IIb期临床中期结果积极。数据显示，慢性乙肝（CHB）患者在接受24周bepirovirsen治疗后，乙肝表面抗原（HBsAg）和乙肝病毒（HBV） DNA的水平降低，有望实现<a href='/topic/show?id=b5a4328934f' target=_blank style='color:#2F92EE;'>#功能性治愈#</a>。, objectTitle=Nat Med：反义寡核苷酸bepirovirsen治疗慢性乙型肝炎疗效, objectType=article, longId=218657, objectId=970f21865eac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/091.jpg, objectUrl=/article/show_article.do?id=970f21865eac, replyNumber=0, likeNumber=54, createdTime=2022-09-17, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=970f21865eac, moduleTitle=Nat Med：反义寡核苷酸bepirovirsen治疗慢性乙型肝炎疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=970f21865eac)], followStatus=false, userIsMember=true, type=1, lengthMark=1), GetTopicListResponse(id=1232707, encodeId=2ba01232e0733, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>坚持学习谢谢学习了学习了谢谢, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=39, createdTime=2022-07-15, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=https://img.medsci.cn/20220201/358c07958b744197a7c86437de41eaae/122444a699eb4ccab6505301ec608ab8.jpg, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1198249, encodeId=536d1198249af, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>学习了。, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=61, createdTime=2022-03-01, rootId=0, userName=moyanju2796, userId=cbcd5675699, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1011908, encodeId=e6f31011908d5, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>自从恩替卡韦进国家医保，造福了广大老百姓, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=79, createdTime=2021-08-27, rootId=0, userName=ms4000000307558628, userId=635c5584190, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1005142, encodeId=f1cc100514291, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>慢性乙肝规范化治疗很重要, objectTitle=慢性乙肝, objectType=topic, longId=53467, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020122/1606873770953_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=71, createdTime=2021-08-04, rootId=0, userName=smart Ren, userId=b3545492917, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=912547, encodeId=21c791254eb8, content=<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>好消息, objectTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, objectType=article, longId=205090, objectId=009e20509087, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201231/1609392602181_5295902.jpeg, objectUrl=/article/show_article.do?id=009e20509087, replyNumber=0, likeNumber=118, createdTime=2020-12-31, rootId=0, userName=rayms, userId=b9f692910, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009e20509087, moduleTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009e20509087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=882426, encodeId=b16b8824264f, content=持续关注<a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a>中国是肝癌大国，乙肝转化的负担最大。期待能早日出现有效药物，救治更多的人！🙏🙏, objectTitle=4周可实现“功能性治愈”！GSK反义寡核苷酸疗法乙肝IIa期研究取得积极结果, objectType=article, longId=200199, objectId=df16200199bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/102373157-95011716.1910x1000.jpg, objectUrl=/article/show_article.do?id=df16200199bb, replyNumber=0, likeNumber=100, createdTime=2020-09-03, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df16200199bb, moduleTitle=4周可实现“功能性治愈”！GSK反义寡核苷酸疗法乙肝IIa期研究取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df16200199bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性乙肝

2020-05-29

雪莲药师 (审核中...)

前往app查看评论内容

#慢性乙肝# 坚持学习打卡谢谢分享谢谢

2023-09-12发表于山东省

13d0179fm99暂无昵称 (审核中...)

前往app查看评论内容

#慢性乙肝# 少熬夜，多运动，预防乙肝

2023-07-13发表于山西省

13d0179fm99暂无昵称 (审核中...)

前往app查看评论内容

#慢性乙肝#慢性乙肝防治，任重道远

2023-06-17

13d0179fm99暂无昵称 (审核中...)

前往app查看评论内容

#慢性乙肝#少熬夜，多运动，预防慢性乙肝

2023-05-30

雪莲药师 (审核中...)

前往app查看评论内容

#慢性乙肝#坚持学习谢谢分享谢谢

2023-05-25

13d0179fm99暂无昵称 (审核中...)

前往app查看评论内容

#慢性乙肝#增强体质，预防乙肝

2023-04-17

雪莲药师 (审核中...)

前往app查看评论内容

#慢性乙肝#坚持学习谢谢分享谢谢分享谢谢

2022-10-17

(审核中...)

前往app查看评论内容

全文收起 #GSK#宣布，#bepirovirsen#（#GSK3228836#、GSK836）治疗#慢性乙肝#的IIb期临床中期结果积极。数据显示，慢性乙肝（CHB）患者在接受24周bepirovirsen治疗后，乙肝表面抗原（HBsAg）和乙肝病毒（HBV） DNA的水平降低，有望实现#功能性治愈#。

Nat Med：反义寡核苷酸bepirovirsen治疗慢性乙型肝炎疗效

2022-09-17

雪莲药师 (审核中...)

前往app查看评论内容

#慢性乙肝#坚持学习谢谢学习了学习了谢谢

2022-07-15

moyanju2796 (审核中...)

前往app查看评论内容

#慢性乙肝#学习了。

2022-03-01

ms4000000307558628 (审核中...)

前往app查看评论内容

#慢性乙肝#自从恩替卡韦进国家医保，造福了广大老百姓

2021-08-27

smart Ren (审核中...)

前往app查看评论内容

#慢性乙肝#慢性乙肝规范化治疗很重要

2021-08-04

rayms (审核中...)

前往app查看评论内容

#慢性乙肝#好消息

新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究

2020-12-31

Psycho.Dr Du (审核中...)

前往app查看评论内容

持续关注#慢性乙肝#中国是肝癌大国，乙肝转化的负担最大。期待能早日出现有效药物，救治更多的人！🙏🙏

4周可实现“功能性治愈”！GSK反义寡核苷酸疗法乙肝IIa期研究取得积极结果

2020-09-03

科室
- - 订阅+
  - 更多科室
工具
服务